Asia Pacific Organ Preservation Solutions Market Segments and Growth by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Asia Pacific Organ Preservation Solutions Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Solution [University of Wisconsin Solution (UW), Custodiol HTK, Perfadex, and Others], Technique (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), and Organ Type (Kidneys, Liver, Lungs, Heart, and Others)

  • Report Date : Nov 2021
  • Report Code : TIPRE00025780
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 123

The organ preservation solutions market in APAC is expected to grow from US$ 43.20 million in 2021 to US$ 70.73 million by 2028; it is estimated to grow at a CAGR of 7.3% from 2021 to 2028.

Australia, China, India, Japan, and South Korea are major economies in APAC. Issues regarding cardiovascular diseases are increasing and this is the major factor driving the growth of the APAC organ preservation solutions market. CVDs are heart and blood vessel disorders, which include cerebrovascular diseases, coronary heart disease, rheumatic heart disease, and other diseases. Tobacco use, unhealthy diet, and physical inactivity, which increase the risk of heart attacks and strokes, are some of the major causes of death and difficulty. CVDs are the world's leading cause of death, affecting more than any other disease.

Cardiovascular diseases are becoming more and more prevalent around the world. Cardiovascular diseases are the world's leading cause of death. According to organdonor.gov, the heart is the third-largest vital organ transplantation performed after kidney and liver. Besides, new technologies for a heart transplant will offer lucrative opportunities for the organ preservation solutions market. Technological innovation also has been playing a critical role in increasing the widespread uptake of organ transplantation. CVD is the biggest cause of death among men and women. Therefore, the increasing need for a heart transplant, owing to the increasing prevalence of cardiovascular diseases, is expected to boost the market growth during the prediction period.

COVID-19 infection has been a serious problem in the patients after organ transplantation. For instance, a study combining data from China and Italy indicated that 27% of highly infected COVID-19 patients required assisted ventilation and had a 21% death rate. Although there have been few recorded cases of COVID-19 infection in transplant patients, deaths have been observed in bone marrow and liver transplant recipients. Organ donation and transplant programmes have also suffered significant setbacks. As a response, the Asian Society of Transplantation (AST) requested member countries to share COVID-19-related statistics and report on their transplantation experiences during the COVID-19 pandemic in order to spur additional organ donation initiatives. Only one transplant center in Bangladesh is still operational. COVID-19 is not routinely checked in donors or recipients unless they are sick. Bangladesh is under lockdown; thus, any follow-up is limited to emergencies. Transplant recipients are urged to call, or video call their transplant healthcare providers.Except for the living donor kidney transplant service, which has been discontinued since mid-February 2020, all transplant programmes in Hong Kong are still operational. Outpatient follow-ups for transplant recipients continue, but the number of visits for stable patients is reduced. COVID-19 has been detected in one kidney transplant recipient. As a result, the organ preservation solution market in the region has seen limited expansion due to the COVID-19 impact.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC organ preservation solutions market. The APAC organ preservation solutions market is expected to grow at a good CAGR during the forecast period.
APAC organ preservation solutions market

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

APAC Organ Preservation Solutions Market Segmentation

 

APAC Organ Preservation Solutions Market – By Solution

  • University of Wisconsin Solution (UW)
  • Custodiol HTK
  • Perfadex
  • Others

APAC Organ Preservation Solutions Market – By Technique

  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion
  • Others

APAC Organ Preservation Solutions Market – By Organ Type

  • Kidneys
  • Liver
  • Lungs
  • Heart
  • Others

APAC Organ Preservation Solutions Market, by Country

  • Australia
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC

APAC Organ Preservation Solutions Market - Companies Mentioned

  • Accord Healthcare
  • Bridge to Life Ltd
  • Dr. Franz Koehler Chemie GmbH
  • Shanghai Genext Pharmaceutical Technology
  • TransMedics
  • Waters Medical Systems LLC
  • XVIVO Perfusion

Asia Pacific Organ Preservation Solutions Report Scope

Report Attribute Details
Market size in 2021 US$ 43.20 Million
Market Size by 2028 US$ 70.73 Million
Global CAGR (2021 - 2028) 7.3%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Solution
  • University of Wisconsin Solution
  • Custodiol HTK
  • Perfadex
By Technique
  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion
By and Organ Type
  • Kidneys
  • Liver
  • Lungs
  • Heart
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Accord Healthcare
  • Bridge to Life Ltd
  • Dr. Franz Koehler Chemie GmbH
  • Shanghai Genext Pharmaceutical Technology
  • TransMedics
  • Waters Medical Systems LLC
  • XVIVO Perfusion
  • Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    1. Accord Healthcare
    2. Bridge to Life Ltd
    3. Dr. Franz Koehler Chemie GmbH
    4. Shanghai Genext Pharmaceutical Technology
    5. TransMedics
    6. Waters Medical Systems LLC
    7. XVIVO Perfusion
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo